Treatment interruptions and regimen changes in first-generation vs. second-generation tyrosine kinase inhibitors used as first-line therapy for chronic myeloid leukemia

Ward, M., Fang, G., Richards, K., Walko, C., Earnshaw, S., & Happe, L. (2015). Treatment interruptions and regimen changes in first-generation vs. second-generation tyrosine kinase inhibitors used as first-line therapy for chronic myeloid leukemia. Journal of Health Economics, 2(2), 181-91.

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Recent Publications

OCCASIONAL PAPER

Bringing an equity-centered framework to research
OCCASIONAL PAPER

The Preschool Entitlement
OCCASIONAL PAPER

Culturally informed community engagement
Article

Does the relationship between alcohol retail environment and alcohol outcomes vary by depressive symptoms? Findings from a US Survey of Black, Hispanic and White drinkers